Thursday, August 2
Clark Chen, M.D., Ph.D. UCSD Neurosurgery
Jonathan Lynn, M.D., Ph.D. UCSD Pathology
Seth Field, M.D., Ph.D. UCSD Internist
The Academic Track for M.D./Ph.D.s: A panel
discussion with early-stage UCSD faculty
Each summer, the Physician Scientist Colloquium hosts faculty
panelists to discuss a topic of interest for the physician scientist community.
At this event, we have invited early-stage MD/PhD UCSD faculty from a
variety of departments to discuss their experiences as academics. The
academic track is one of many available to MSTP graduates, but it is often considered the "default"
path. We hope this event will be informative and will offer current
students a deep and honest look at this career path. We look forward to a
stimulating discussion from Dr. Chen (Neurosurgery), Dr. Lin (Pathology)
and Seth Field (Internal Medicine), moderated by MSTP student Sagar Bapat
Seung K. Kim, M.D., Ph.D. Director of the Stanford MSTP HHMI, Professor of Developmental Biology
Dr. Kim's experiences as a Physician Scientist and the Director of
Stanford's MST program
Dr. Seung Kim is a Howard Hughes Medical Investigator and Professor of
Developmental Biology at Stanford University. His research lab has
pioneered new approaches to create, expand, and regenerate pancreatic islet
cells and also studies pancreatic development and growth. He is also
a graduate of
Stanford's Medical Scientist Training Program (1992), AND sixteen years later,
in 2008, he became the program's Director! Which one of the current MSTPs
will be taking over Paul's position sixteen years from now???
Thursday, March 22
Harry E. Gruber, M.D. Tocagen Inc. President/CEO/Chairman
Research in Progress: Joshua Theisen MSTP student, Kadonaga Lab
Career Perspectives: Experiences in Industry
Dr. Gruber holds a BA and a MD from the University of Pennsylvania.
After 9 years at UCSD as a geneticist, rheumatologist and researcher,
Dr. Gruber began a career in industry by founding Gensia, Inc. in
1986, one of the earliest gene therapy firms which went public in 1990 and had
a market cap of $1.7 billion. Dr. Gruber founded web-based
solutions companies Intervu (sold for 2.8 billion... yes, with
a "b") and Kintera (helping non-profits raise money
and awareness) in the 90s, and now runs Tocagen, a company
dedicated to the development and commercialization of breakthrough
treatments for cancer using advanced gene transfer technologies
Dan Littman M.D. Ph.D.
Professor of Molecular Immunology and Professor of Pathology and Microbiology,
Howard Hughes Medical Institute Investigator, New York University Langone
Research in Progress: Justin Voog, Ph.D. MSTP Student
Career Perspectives: Dan Littman has worked on HIV for nearly 30 years, cloned CD4
while working with Richard Axel at Columbia University, is a giant in the field
of T-cell development and biology, and has been an HHMI Investigator for over
20 years at both UC San Francisco and New York University.
Paul Mischel, MD Professor of Pathology and Laboratory
Medicine, Dept. of Molecular and Medical Pharmacology, David Geffen School of
Research in Progress: Michael
Lam, Ph.D. MSTP Student - Glass Lab
Career Perspectives: Paul Mischel,
MD, is the
Lya and Harrison Latta Professor of Pathology and Laboratory Medicine at
the Department of Molecular and Medical Pharmacology and the David Geffen
School of Medicine at UCLA. Dr. Mischel graduated Alpha Omega Alpha with an M.D. from Cornell University Medical
College and trained in Anatomic Pathology and Neuropathology at UCLA. Dr.Mischel obtained his post-doctoral research training in the laboratory of Dr.
Louis F. Reichardt at the Howard Hughes Medical Institute at UCSF and joined
the UCLA faculty in 1998. Dr.Mischel has received a number of awards, including the Farber Award in 2007, the
top brain tumor research award given jointly by the Society for Neuro-oncology
and the American Association of Neurosurgery.
Come hear Paul Mischel reflect on his career choices and his
perspective on the life of a physician scientist and the biomedical sciences at
our next Physician Scientist Colloquium.